Early Stage

Revenue Cycle Management that makes lives better.

Revenue Cycle Management that makes lives better.


Raised this Round: Raised: $22,000



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type


SEC Filing Type

RegD 506(b)    Open SEC Filing

Year Founded



Business Services, Software, & Applications

Tech Sector



San Francisco, California

Enter.Health is raising funds through EN14 Fund I, a series of Roll Up Vehicles via a Reg D 506(b) raise. It is a series LP investment fund under Roll Up Vehicles of AngelList that allows investors to receive a single link and commit and send funds online. Enter.Health has developed a revenue cycle management platform for medical billing services in healthcare. The platform offers complete claim creation, EMR integration, and complete automation of appeals, benefits, patient statements, and patient collection. Jordan Kelley founded Enter.Health in 2016. The current campaign has a maximum target of $22,000.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Enter.Health on AngelList 2022
Platform: Angellist
Security Type: SAFE

Follow company

Follow Enter.Health on AngelList 2022
No Public Offering Page

Buy Enter.Health's Deal Report

Warning: according to the close date for this deal, Enter.Health may no longer be accepting investments.

Enter.Health Deal Report

Get KingsCrowd’s comprehensive report on Enter.Health including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Enter.Health is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Enter.Health deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge